Send us a text
Grab your trainers, your dog lead, or a cuppa and join us for some free CPD as we have another relaxed round up of recent Red Whale primary care Pearls of wisdom. In the second of two episodes this month, Fiona and Nik discuss:
- Spinal cord compression and cauda equina syndrome. They’re on our (long!) list of things we never want to miss. They’re uncommon presentations, but they cause us a lot of anxiety. We can help…
- The new NICE guidance on menopause, published in December 2024. Much stayed the same, but we focus on the bits that may change our practice…
Listen as soon as you can to ensure you have full access to all the free resources.
And hear a best intentions story that will have you checking your phone and your headphones before launching into your next consultation!
Spinal cord compression and cauda equina syndrome
Red flags to screen for malignancy and fracture in patients with low back pain: systematic review
BMJ 2013;347:f7095
GRIFT 2023 cauda equina
national suspected cauda equina pathway
Musculoskeletal Association of Chartered Physiotherapists – cauda equina information cards (cards in 29 different languages)
NICE guideline on menopause 2024: practice-changing points
NICE NG23
BMS statement in response to the publication of the updated NICE Menopause guideline (NG23)
Send us your feedback podcast@redwhale.co.uk or send a voice message
Sign up to receive Pearls here. Pearls are available for 3 months from publish date. After this, you can get access them plus 100s more articles when you buy a one-day online course from Red Whale OR sign up to Red Whale Unlimited. Find out more here.
Follow us: X, Facebook, Instagram, LinkedIn
Disclaimer: We make every effort to ensure the information in this podcast is accurate and correct at the date of publication, but it is of necessity of a brief and general nature, and this should not replace your own good clinical judgement, or be regarded as a substitute for taking professional advice in appropriate circumstances. In particular, check drug doses, side-effects and interactions with the British National Formulary. Save insofar as any such liability cannot be excluded at law, we do not accept any liability for loss of any type caused by reliance on the information in this podcast.
...
